|
1
|
Papadopoulos DP and Papademetriou V:
Metoprolol succinate combination in the treatment of hypertension.
Angiology. 60:608–613. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reiter MJ: Cardiovascular drug class
specificity: Beta-blockers. Prog Cardiovasc Dis. 47:11–33. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Frishman WH and Saunders E: β-Adrenergic
blockers. J Clin Hypertens (Greenwich). 13:649–653. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bengtsson C, Johnsson G and Regårdh CG:
Plasma levels and effects of metoprolol on blood pressure and heart
rate in hypertensive patients after an acute dose and between two
doses during long-term treatment. Clin Pharmacol Ther. 17:400–408.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guan G and Li Z: Evaluation of the effect
on metoprolol succinate sustained release tablets in reducing blood
pressure. Jian Yan Yi Xue Yu Lin Chuang. 6:1989–1990. 2009.(In
Chinese).
|
|
6
|
Chirra HD and Desai TA: Emerging
microtechnologies for the development of oral drug delivery
devices. Adv Drug Deliv Rev. 64:1569–1578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu B, Wen R, Yang H and He Y:
Sustained-release tablets of indomethacin-loaded microcapsules:
Preparation, in vitro and in vivo characterization. Int J Pharm.
333:87–94. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Frishman WH, Hainer JW and Sugg J; M-FACT
Study Group, : A factorial study of combination hypertension
treatment with metoprolol succinate extended release and felodipine
extended release results of the Metoprolol Succinate-Felodipine
Antihypertension Combination Trial (M-FACT). Am J Hypertens.
19:388–395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siddique S, Khanam J and Bigoniya P:
Development of sustained release capsules containing ‘coated matrix
granules of metoprolol tartrate’. AAPS PharmSciTech. 11:1306–1314.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gong X, Lu Y, Xiang Z and Luo G:
Preparation of polysulfone microcapsules containing 1-octanol for
the recovery of caprolactam. J Microencapsul. 26:104–110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Zhu Y, Wang J, Sun Y, Li S and
Pan W: Preparation of sustained-release microspheres of
clarithromycin by quasi-emulsion solvent diffusion method. Zhongguo
Yao Ye. 18:39–40. 2009.(In Chinese).
|
|
12
|
You J, Cui FD, Han X, Wang YS, Yang L, Yu
YW and Li QP: Study of the preparation of sustained-release
microspheres containing zedoary turmeric oil by the
emulsion-solvent-diffusion method and evaluation of the
self-emulsification and bioavailability of the oil. Colloids Surf B
Biointerfaces. 48:35–41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jelvehgari M and Montazam SH: Comparison
of microencapsulation by emulsion-solvent extraction/evaporation
technique using derivatives cellulose and acrylate-methacrylate
copolymer as carriers. Jundishapur J Nat Pharm Prod. 7:144–152.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dash V, Mishra SK, Singh M, Goyal AK and
Rath G: Release kinetic studies of aspirin microcapsules from ethyl
cellulose, cellulose acetate phthalate and their mixtures by
emulsion solvent evaporation method. Sci Pharm. 78:93–101. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saringat HB, Alfadol KI and Khan GM: The
influence of different plasticizers on some physical and mechanical
properties of hydroxypropyl methylcellulose free films. Pak J Pharm
Sci. 18:25–38. 2005.PubMed/NCBI
|
|
16
|
Huang G, Deng S, Wang R and Xi Y:
Preparation and in vitro-in vivo correlation in dogs of metoprolol
succinate sustained-released tablets. Zhongguo Yi Yao Gong Ye Za
Zhi. 36:412–414. 2005.(In Chinese).
|
|
17
|
Xu W, Li N and Gao C: Preparation of
controlled porosity osmotic pump tablets for salvianolic acid an
doptimization of the formulation using an artificial neural network
method. Acta Pharm Sin B. 1:64–70. 2011. View Article : Google Scholar
|
|
18
|
Shen LN, Zhang YT, Wang Q, Xu L and Feng
NP: Enhanced in vitro and in vivo skin deposition of apigenin
delivered using ethosomes. Int J Pharm. 460:280–288. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saurí J, Millán D, Suñé-Negre JM, Colom H,
Ticó JR, Miñarro M, Pérez-Lozano P and García-Montoya E: Quality by
design approach to understand the physicochemical phenomena
involved in controlled release of captopril SR matrix tablets. Int
J Pharm. 477:431–441. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Albin P, Markus A, Ben-Zvi Z and Pelah Z:
A new slow release formulation of metoprolol: In-vitro and in-vivo
evaluation in dogs. J Control Release. 23:1–11. 1993. View Article : Google Scholar
|
|
21
|
Liu Y, Feng Y and Xu D: Influence of
excipients on the mechanical properties of microcapsules. Chin
Traditional Pat Med. 29:1602–1605. 2007.
|
|
22
|
Zhao W: Uniform design application in
pharmaceutics. Anhui Med Pharm J. 14:610–612. 2010.
|
|
23
|
Pradhan R, Kim YI, Chang SW and Kim JO:
Preparation and evaluation of once-daily sustained-release coated
tablets of tolterodine-L-tartrate. Int J Pharm. 460:205–211. 2014.
View Article : Google Scholar : PubMed/NCBI
|
